{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:35:25Z","timestamp":1762101325428},"reference-count":49,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.vaccine.2012.06.074","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T04:41:23Z","timestamp":1341636083000},"page":"5453-5458","source":"Crossref","is-referenced-by-count":10,"title":["Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers"],"prefix":"10.1016","volume":"30","author":[{"given":"Konstantin","family":"Virnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Berkower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0005","first-page":"117","article-title":"Reminiscences of Albert Sabin and his successful strategy for the development of the live oral poliovirus vaccine","volume":"108","author":"Chanock","year":"1996","journal-title":"Proc Assoc Am Physicians"},{"issue":"December (6353)","key":"10.1016\/j.vaccine.2012.06.074_bib0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition","volume":"354","author":"Phillips","year":"1991","journal-title":"Nature"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.06.074_bib0015","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1128\/JVI.65.11.5983-5990.1991","article-title":"A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120","volume":"65","author":"Berkower","year":"1991","journal-title":"J Virol"},{"issue":"September (6049)","key":"10.1016\/j.vaccine.2012.06.074_bib0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"September (6049)","key":"10.1016\/j.vaccine.2012.06.074_bib0025","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"issue":"December (5090)","key":"10.1016\/j.vaccine.2012.06.074_bib0030","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.1470917","article-title":"Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene","volume":"258","author":"Daniel","year":"1992","journal-title":"Science"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/5557","article-title":"Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques","volume":"5","author":"Baba","year":"1999","journal-title":"Nat Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.06.074_bib0040","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/JVI.68.3.2031-2037.1994","article-title":"Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene","volume":"68","author":"Kirchhoff","year":"1994","journal-title":"J Virol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/viro.2001.1345","article-title":"Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model","volume":"294","author":"Earl","year":"2002","journal-title":"Virology"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2012.06.074_bib0050","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/JVI.02453-06","volume":"81","author":"Demberg","year":"2007","journal-title":"J Virol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.06.074_bib0055","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JVI.78.5.2212-2221.2004","article-title":"Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting","volume":"78","author":"Patterson","year":"2004","journal-title":"J Virol"},{"issue":"January (6869)","key":"10.1016\/j.vaccine.2012.06.074_bib0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"issue":"May (7348)","key":"10.1016\/j.vaccine.2012.06.074_bib0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2012.06.074_bib0070","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1016\/j.vaccine.2005.05.034","article-title":"Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660","volume":"23","author":"Johnston","year":"2005","journal-title":"Vaccine"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0075","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.74.2.914-922.2000","article-title":"Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis","volume":"74","author":"MacDonald","year":"2000","journal-title":"J Virol"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.06.074_bib0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2012.06.074_bib0090","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.06.074_bib0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"Bonaldo","year":"2007","journal-title":"Virol J"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.06.074_bib0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2012.06.074_bib0105","series-title":"Vaccines","first-page":"707","article-title":"Rubella vaccine","author":"Plotkin","year":"2004"},{"issue":"May (RR-8)","key":"10.1016\/j.vaccine.2012.06.074_bib0110","first-page":"1","article-title":"Measles, mumps, and rubella\u2014vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/JVI.71.1.562-568.1997","article-title":"Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins","volume":"71","author":"Pugachev","year":"1997","journal-title":"J Virol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/viro.2000.0408","article-title":"Infectious cDNA clone of the RA27\/3 vaccine strain of Rubella virus","volume":"273","author":"Pugachev","year":"2000","journal-title":"Virology"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2012.06.074_bib0125","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.vaccine.2009.11.037","article-title":"Stable expression of a foreign protein by a replication-competent rubella viral vector","volume":"28","author":"Spadaccini","year":"2010","journal-title":"Vaccine"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/viro.2001.1088","article-title":"Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus","volume":"289","author":"Tzeng","year":"2001","journal-title":"Virology"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2012.06.074_bib0135","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1128\/JVI.77.17.9502-9510.2003","article-title":"Complementation of a deletion in the rubella virus p150 nonstructural protein by the viral capsid protein","volume":"77","author":"Tzeng","year":"2003","journal-title":"J Virol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2012.06.074_bib0140","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.1128\/JVI.74.22.10811-10815.2000","article-title":"Development of a rubella virus vaccine expression vector: use of a picornavirus internal ribosome entry site increases stability of expression","volume":"74","author":"Pugachev","year":"2000","journal-title":"J Virol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.06.074_bib0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.95.4.743","article-title":"Experimental rubella virus infection in the rhesus monkey","volume":"95","author":"Parkman","year":"1965","journal-title":"J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.06.074_bib0150","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.73.9.7805-7811.1999","article-title":"Intracellular distribution of rubella virus nonstructural protein P150","volume":"73","author":"Kujala","year":"1999","journal-title":"J Virol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.06.074_bib0155","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"December (18)","key":"10.1016\/j.vaccine.2012.06.074_bib0160","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/JVI.75.2.738-749.2001","article-title":"CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing","volume":"75","author":"Allen","year":"2001","journal-title":"J Virol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2012.06.074_bib0170","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.173.8.5064","article-title":"Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition","volume":"173","author":"Loffredo","year":"2004","journal-title":"J Immunol"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2012.06.074_bib0175","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1073\/pnas.0813106106","article-title":"Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection","volume":"106","author":"Sacha","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (6 Pt 1)","key":"10.1016\/j.vaccine.2012.06.074_bib0180","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1083\/jcb.107.6.2075","article-title":"Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes","volume":"107","author":"Froshauer","year":"1988","journal-title":"J Cell Biol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.06.074_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01321120","article-title":"Replication complexes associated with the morphogenesis of rubella virus","volume":"122","author":"Lee","year":"1992","journal-title":"Arch Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/viro.2001.0862","article-title":"Rubella virus RNA replication is cis-preferential and synthesis of negative- and positive-strand RNAs is regulated by the processing of nonstructural protein","volume":"282","author":"Liang","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.06.074_bib0195","series-title":"Fundamental immunology","first-page":"631","article-title":"Immunogenicity and antigen structure","author":"Berzofsky","year":"2008"},{"key":"10.1016\/j.vaccine.2012.06.074_bib0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0065-3527(08)60328-0","article-title":"Molecular biology of rubella virus","volume":"44","author":"Frey","year":"1994","journal-title":"Adv Virus Res"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2012.06.074_bib0205","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.02588-06","article-title":"An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10","volume":"81","author":"Nelson","year":"2007","journal-title":"J Virol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.00020-07","article-title":"The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design","volume":"72","author":"Montero","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0912914107","article-title":"Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance","volume":"107","author":"Verkoczy","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.06.074_bib0220","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/JVI.76.2.875-884.2002","article-title":"Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection","volume":"76","author":"Mothe","year":"2002","journal-title":"J Virol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2012.06.074_bib0225","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1128\/JVI.76.22.11623-11636.2002","article-title":"Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?","volume":"76","author":"Vogel","year":"2002","journal-title":"J Virol"},{"issue":"November (46)","key":"10.1016\/j.vaccine.2012.06.074_bib0230","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (5361)","key":"10.1016\/j.vaccine.2012.06.074_bib0235","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","article-title":"Viral strategies of immune evasion","volume":"280","author":"Ploegh","year":"1998","journal-title":"Science"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.06.074_bib0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2007.11.005","article-title":"Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles","volume":"373","author":"Phogat","year":"2008","journal-title":"Virology"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.06.074_bib0245","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JVI.02061-10","article-title":"Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence","volume":"85","author":"Berkower","year":"2011","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T04:15:22Z","timestamp":1687580122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":49,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0264410X12009553"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}